Indeed, a previous study showed that in murine normal cardiomyocytes, PRMT5 could inhibit the Wnt/β-catenin pathway to protect against pathological cardiac hypertrophy 70. This evidence concerns the gene PRMT5 and cardiac hypertrophy.